{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T20:23:50Z","timestamp":1770495830873,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Urine-metanephrines are used in the screening for pheochromocytomas in patients with adrenal incidentalomas, but their potential as markers for mortality in patients with adrenal adenomas has not been studied. A retrospective cohort study was designed to investigate if urine-metanephrines were associated with mortality in patients with adrenal adenomas. Participants where consecutively included between 2005 and 2015 at two endocrine centres in southern Sweden and followed until December 31st, 2022. The exposures were 24\u00a0h-urine (tU) metanephrine and normetanephrine analysed at inclusion. The endpoint was all-cause mortality. Outcome data were obtained from the Cause of Death Register. 879 adult (\u2265\u200918\u00a0years) patients with an incidentally discovered adrenal adenoma were included in the study and followed for a median of 9.9\u00a0years. Median age of patients was 66.7\u00a0years, and 59.6% were women. 278 patients died during follow-up. tU-normetanephrine was associated with increased mortality, adjusted hazard ratio (HR) 1.47 (95% CI, 1.27\u20131.69) (HR for an increase of 100\u00a0\u03bcmol\/mol creatinine). There was no significant association between tU-metanephrine and mortality, HR 0.96 (0.64\u20131.43). tU-normetanephrine seems to be a predictor for mortality in patients with adrenal adenomas. This widely available diagnostic test may be helpful in further risk-stratifying patients with adrenal adenomas.<\/jats:p>","DOI":"10.1038\/s41598-025-94951-w","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T19:59:53Z","timestamp":1743537593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Urine-normetanephrine, a predictor of mortality risk in patients with adrenal adenomas"],"prefix":"10.1038","volume":"15","author":[{"given":"Albin","family":"Kjellbom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"L\u00f6ndahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malin","family":"Danielsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"94951_CR1","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht, M. et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 189, G1\u2013G42. https:\/\/doi.org\/10.1093\/ejendo\/lvad066 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"94951_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","volume":"2","author":"G Di Dalmazi","year":"2014","unstructured":"Di Dalmazi, G. et al. Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing\u2019s syndrome: A 15-year retrospective study. Lancet Diabetes Endocrinol. 2, 396\u2013405. https:\/\/doi.org\/10.1016\/S2213-8587(13)70211-0 (2014).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"94951_CR3","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1210\/jc.2014-3007","volume":"99","author":"M Debono","year":"2014","unstructured":"Debono, M. et al. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. J. Clin. Endocrinol. Metab. 99, 4462\u20134470. https:\/\/doi.org\/10.1210\/jc.2014-3007 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94951_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s12020-017-1400-8","volume":"58","author":"J Patrova","year":"2017","unstructured":"Patrova, J., Kjellman, M., Wahrenberg, H. & Falhammar, H. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: A 13-year retrospective study from one center. Endocrine 58, 267\u2013275. https:\/\/doi.org\/10.1007\/s12020-017-1400-8 (2017).","journal-title":"Endocrine"},{"key":"94951_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.7326\/M20-7946","volume":"174","author":"A Kjellbom","year":"2021","unstructured":"Kjellbom, A., Lindgren, O., Puvaneswaralingam, S., Londahl, M. & Olsen, H. Association between mortality and levels of autonomous cortisol secretion by adrenal incidentalomas: A cohort study. Ann. Intern. Med. 174, 1041\u20131049. https:\/\/doi.org\/10.7326\/M20-7946 (2021).","journal-title":"Ann. Intern. Med."},{"key":"94951_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(22)00100-0","author":"T Deutschbein","year":"2022","unstructured":"Deutschbein, T. et al. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: An international, retrospective, cohort study. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/s2213-8587(22)00100-0 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"94951_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1042\/cs0880533","volume":"88","author":"G Eisenhofer","year":"1995","unstructured":"Eisenhofer, G. et al. Plasma metadrenalines: Do they provide useful information about sympatho-adrenal function and catecholamine metabolism?. Clin. Sci. 88, 533\u2013542. https:\/\/doi.org\/10.1042\/cs0880533 (1995).","journal-title":"Clin. Sci."},{"key":"94951_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jacc.2009.03.061","volume":"54","author":"JS Floras","year":"2009","unstructured":"Floras, J. S. Sympathetic nervous system activation in human heart failure: Clinical implications of an updated model. J. Am. Coll. Cardiol. 54, 375\u2013385. https:\/\/doi.org\/10.1016\/j.jacc.2009.03.061 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"94951_CR9","doi-asserted-by":"publisher","first-page":"919422","DOI":"10.3389\/fphys.2022.919422","volume":"13","author":"J Spiesshoefer","year":"2022","unstructured":"Spiesshoefer, J. et al. Sympathetic and vagal nerve activity in COPD: Pathophysiology, presumed determinants and underappreciated therapeutic potential. Front. Physiol. 13, 919422. https:\/\/doi.org\/10.3389\/fphys.2022.919422 (2022).","journal-title":"Front. Physiol."},{"key":"94951_CR10","doi-asserted-by":"publisher","first-page":"14913","DOI":"10.1038\/s41598-022-19321-2","volume":"12","author":"M Parasiliti-Caprino","year":"2022","unstructured":"Parasiliti-Caprino, M. et al. A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma. Sci. Rep. 12, 14913. https:\/\/doi.org\/10.1038\/s41598-022-19321-2 (2022).","journal-title":"Sci. Rep."},{"key":"94951_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10091967","author":"M Parasiliti-Caprino","year":"2021","unstructured":"Parasiliti-Caprino, M. et al. Association of urine metanephrine levels with cardiometabolic risk: An observational retrospective study. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm10091967 (2021).","journal-title":"J. Clin. Med."},{"key":"94951_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0004563217739931","volume":"55","author":"AS Davison","year":"2018","unstructured":"Davison, A. S., Jones, D. M., Ruthven, S., Helliwell, T. & Shore, S. L. Clinical evaluation and treatment of phaeochromocytoma. Ann. Clin. Biochem. 55, 34\u201348. https:\/\/doi.org\/10.1177\/0004563217739931 (2018).","journal-title":"Ann. Clin. Biochem."},{"key":"94951_CR13","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/cen.14180","volume":"92","author":"GA Kline","year":"2020","unstructured":"Kline, G. A., Boyd, J., Leung, A. A., Tang, A. & Sadrzadeh, H. M. Moderate renal impairment does not preclude the accuracy of 24-hour urine normetanephrine measurements for suspected pheochromoctyoma. Clin. Endocrino.l (Oxf.) 92, 518\u2013524. https:\/\/doi.org\/10.1111\/cen.14180 (2020).","journal-title":"Clin. Endocrino.l (Oxf.)"},{"key":"94951_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1258\/acb.2008.008180","volume":"46","author":"MJ Whiting","year":"2009","unstructured":"Whiting, M. J. Simultaneous measurement of urinary metanephrines and catecholamines by liquid chromatography with tandem mass spectrometric detection. Ann. Clin. Biochem. 46, 129\u2013136. https:\/\/doi.org\/10.1258\/acb.2008.008180 (2009).","journal-title":"Ann. Clin. Biochem."},{"key":"94951_CR15","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296\u20131305. https:\/\/doi.org\/10.1056\/NEJMoa041031 (2004).","journal-title":"N. Engl. J. Med."},{"key":"94951_CR16","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1097\/ede.0000000000000864","volume":"29","author":"MB Mathur","year":"2018","unstructured":"Mathur, M. B., Ding, P., Riddell, C. A. & VanderWeele, T. J. Web site and R package for computing E-VALUES. Epidemiology 29, e45\u2013e47. https:\/\/doi.org\/10.1097\/ede.0000000000000864 (2018).","journal-title":"Epidemiology"},{"key":"94951_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/m16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele, T. J. & Ding, P. Sensitivity analysis in observational research: Introducing the E-value. Ann. Intern. Med. 167, 268\u2013274. https:\/\/doi.org\/10.7326\/m16-2607 (2017).","journal-title":"Ann. Intern. Med."},{"key":"94951_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer, G., Kopin, I. J. & Goldstein, D. S. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. Pharmacol. Rev. 56, 331\u2013349. https:\/\/doi.org\/10.1124\/pr.56.3.1 (2004).","journal-title":"Pharmacol. Rev."},{"key":"94951_CR19","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/clinchem\/47.6.988","volume":"47","author":"G Eisenhofer","year":"2001","unstructured":"Eisenhofer, G. Free or total metanephrines for diagnosis of pheochromocytoma: What is the difference?. Clin. Chem. 47, 988\u2013989 (2001).","journal-title":"Clin. Chem."},{"key":"94951_CR20","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1124\/jpet.103.049270","volume":"305","author":"DS Goldstein","year":"2003","unstructured":"Goldstein, D. S., Eisenhofer, G. & Kopin, I. J. Sources and significance of plasma levels of catechols and their metabolites in humans. J. Pharmacol. Exp. Ther. 305, 800\u2013811. https:\/\/doi.org\/10.1124\/jpet.103.049270 (2003).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"94951_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/hypertensionaha.118.12050","volume":"73","author":"G Grassi","year":"2019","unstructured":"Grassi, G. & Mancia, G. Masked uncontrolled hypertension. Hypertension 73, 39\u201341. https:\/\/doi.org\/10.1161\/hypertensionaha.118.12050 (2019).","journal-title":"Hypertension"},{"key":"94951_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1161\/01.cir.95.1.169","volume":"95","author":"B Rundqvist","year":"1997","unstructured":"Rundqvist, B., Elam, M., Bergmann-Sverrisdottir, Y., Eisenhofer, G. & Friberg, P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95, 169\u2013175. https:\/\/doi.org\/10.1161\/01.cir.95.1.169 (1997).","journal-title":"Circulation"},{"key":"94951_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.ehj.2003.10.030","volume":"25","author":"R Latini","year":"2004","unstructured":"Latini, R. et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur. Heart J. 25, 292\u2013299. https:\/\/doi.org\/10.1016\/j.ehj.2003.10.030 (2004).","journal-title":"Eur. Heart J."},{"key":"94951_CR24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jjcc.2013.12.009","volume":"64","author":"K Yufu","year":"2014","unstructured":"Yufu, K. et al. Plasma norepinephrine is an independent predictor of adverse cerebral and cardiovascular events in type 2 diabetic patients without structural heart disease. J. Cardiol. 64, 225\u2013230. https:\/\/doi.org\/10.1016\/j.jjcc.2013.12.009 (2014).","journal-title":"J. Cardiol."},{"key":"94951_CR25","doi-asserted-by":"publisher","first-page":"M618","DOI":"10.1093\/gerona\/55.10.m618","volume":"55","author":"DB Reuben","year":"2000","unstructured":"Reuben, D. B., Talvi, S. L., Rowe, J. W. & Seeman, T. E. High urinary catecholamine excretion predicts mortality and functional decline in high-functioning, community-dwelling older persons: MacArthur Studies of Successful Aging. J. Gerontol. A 55, M618\u2013M624. https:\/\/doi.org\/10.1093\/gerona\/55.10.m618 (2000).","journal-title":"J. Gerontol. A"},{"key":"94951_CR26","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1001\/jamainternmed.2023.2442","volume":"183","author":"J Patrova","year":"2023","unstructured":"Patrova, J., Mannheimer, B., Lindh, J. D. & Falhammar, H. Mortality in patients with nonfunctional adrenal tumors. JAMA Intern. Med. 183, 832\u2013838. https:\/\/doi.org\/10.1001\/jamainternmed.2023.2442 (2023).","journal-title":"JAMA Intern. Med."},{"key":"94951_CR27","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad074","author":"A Kjellbom","year":"2023","unstructured":"Kjellbom, A., Lindgren, O., Danielsson, M., Olsen, H. & L\u00f6ndahl, M. Mortality not increased in patients with non-functional adrenal adenomas: A matched cohort study. J. Clin. Endocrinol. Metab. https:\/\/doi.org\/10.1210\/clinem\/dgad074 (2023).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94951_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1530\/eje-20-0033","volume":"183","author":"H Olsen","year":"2020","unstructured":"Olsen, H., Kjellbom, A., L\u00f6ndahl, M. & Lindgren, O. High prevalence of smoking in patients with adrenal incidentalomas: Causality or case selection?. Eur. J. Endocrinol. 183, 335\u2013341. https:\/\/doi.org\/10.1530\/eje-20-0033 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"94951_CR29","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.1210\/clinem\/dgab468","volume":"106","author":"CD Zhang","year":"2021","unstructured":"Zhang, C. D. et al. Cardiometabolic outcomes and mortality in patients with adrenal adenomas in a population-based setting. J. Clin. Endocrinol. Metab 106, 3320\u20133330. https:\/\/doi.org\/10.1210\/clinem\/dgab468 (2021).","journal-title":"J. Clin. Endocrinol. Metab"},{"key":"94951_CR30","doi-asserted-by":"publisher","first-page":"111258","DOI":"10.1016\/j.mce.2021.111258","volume":"528","author":"N Bechmann","year":"2021","unstructured":"Bechmann, N., Berger, I., Bornstein, S. R. & Steenblock, C. Adrenal medulla development and medullary-cortical interactions. Mol. Cell Endocrinol. 528, 111258. https:\/\/doi.org\/10.1016\/j.mce.2021.111258 (2021).","journal-title":"Mol. Cell Endocrinol."},{"key":"94951_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.coemr.2019.06.005","volume":"8","author":"SR Bornstein","year":"2019","unstructured":"Bornstein, S. R., Berger, I., Scriba, L., Santambrogio, A. & Steenblock, C. Adrenal cortex\u2013medulla interactions in adaptation to stress and disease. Curr. Opin. Endocr. Metab. Res. 8, 9\u201314. https:\/\/doi.org\/10.1016\/j.coemr.2019.06.005 (2019).","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"key":"94951_CR32","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/SHK.0b013e3181af0633","volume":"33","author":"RI Sharara-Chami","year":"2010","unstructured":"Sharara-Chami, R. I., Joachim, M., Pacak, K. & Majzoub, J. A. Glucocorticoid treatment\u2014effect on adrenal medullary catecholamine production. Shock 33, 213\u2013217. https:\/\/doi.org\/10.1097\/SHK.0b013e3181af0633 (2010).","journal-title":"Shock"},{"key":"94951_CR33","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1749-6632.2012.06623.x","volume":"1261","author":"I Pilipovi\u0107","year":"2012","unstructured":"Pilipovi\u0107, I., Radojevi\u0107, K., Peri\u0161i\u0107, M. & Leposavi\u0107, G. Glucocorticoid-catecholamine interplay within the composite thymopoietic regulatory network. Ann. N. Y. Acad. Sci. 1261, 34\u201341. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06623.x (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"94951_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1124\/jpet.116.234005","volume":"358","author":"AE Soto-Pi\u00f1a","year":"2016","unstructured":"Soto-Pi\u00f1a, A. E. et al. A novel model of dexamethasone-induced hypertension: Use in investigating the role of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 358, 528\u2013536. https:\/\/doi.org\/10.1124\/jpet.116.234005 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"94951_CR35","doi-asserted-by":"publisher","first-page":"e3374","DOI":"10.1210\/clinem\/dgaa423","volume":"105","author":"G Constantinescu","year":"2020","unstructured":"Constantinescu, G. et al. Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension. J. Clin. Endocrinol. Metab. 105, e3374-3383. https:\/\/doi.org\/10.1210\/clinem\/dgaa423 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"94951_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20123065","author":"E Ventura Spagnolo","year":"2019","unstructured":"Ventura Spagnolo, E. et al. Post-mortem immunohistochemical evidence of \u03b22-adrenergic receptor expression in the adrenal gland. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20123065 (2019).","journal-title":"Int. J. Mol. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94951-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94951-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T09:23:10Z","timestamp":1743758590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-94951-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["94951"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-94951-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"28 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ML is an employee of Eli Lilly and Company.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11145"}}